The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3

Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action

(2009) Zachary Freyberg et al.   AMERICAN JOURNAL OF PSYCHIATRY

Dishevelled: The hub of Wnt signaling

(2009) Chan Gao et al.   CELLULAR SIGNALLING

Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases

(2009) Bryan T. MacDonald et al.   DEVELOPMENTAL CELL

Regulation of Serotonin 1B Receptor by Glycogen Synthase Kinase-3

(2009) L. Chen et al.   MOLECULAR PHARMACOLOGY

Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3β in adrenal chromaffin cells: Effects of LiCl and SB216763

(2008) Takayuki Nemoto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Antagonism of dopamine D2 receptor/ -arrestin 2 interaction is a common property of clinically effective antipsychotics

(2008) B. Masri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response

(2008) Renan P. Souza et al.   PSYCHOPHARMACOLOGY

Positional Pathway Screen of wnt Signaling Genes in Schizophrenia: Association with DKK4

(2007) Petroula Proitsi et al.   BIOLOGICAL PSYCHIATRY

AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families

(2007) Dawn L. Thiselton et al.   BIOLOGICAL PSYCHIATRY